PMID: 9428054Jan 15, 1998Paper

Risk of long-term disability among patients with back pain

Scandinavian Journal of Rehabilitation Medicine
A H IngemarssonT Sivik

Abstract

The aim of this study was to find predictors of length of time on sick-leave and the change in sick-leave as a result of intervention. Many studies of back pain show that medical and psychosocial factors covary with length of sick-leave. The results are based on the questionnaire responses of 240 patients. A stepwise multiple regression showed that the significant predictors of number of sick-days the year after intervention were the number of sick-days before the intervention and also hypochondria. Significant predictors of sick-leave change were sleep disturbance and number of sick-days before intervention. A discriminant function analysis comparing a group that had decreased its sick-leave with one that had increased its sick-leave showed 7 predictors of increased sick-leave: high risk of somatisation; many children and family members living at home; a change in tasks at work owing to pain; brothers and sisters with longstanding pain problems; frequent pain, and sleep disturbance. It is important for physiotherapists to enquire about patients' earlier sick-leave patterns in order to identify risk factors for long-term disability among patients with back pain. Some of these factors have been identified in this study.

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.